Emergent BioSolutions gets $24M contract modification for CYFENDUS
Emergent BioSolutions (EBS) was awarded a contract modification valued at approximately $24 million for CYFENDUS®.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.